PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Medifast, Inc. (MED)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS58470H1014
CUSIP58470H101
SectorConsumer Cyclical
IndustryPersonal Services

Highlights

Market Cap$417.52M
EPS$9.10
PE Ratio4.21
PEG Ratio1.95
Revenue (TTM)$1.07B
Gross Profit (TTM)$1.14B
EBITDA (TTM)$139.51M
Year Range$34.09 - $107.29
Target Price$37.50
Short %28.57%
Short Ratio3.92

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Medifast, Inc.

Popular comparisons: MED vs. CBRL, MED vs. JWN, MED vs. SCHD, MED vs. NEE, MED vs. HD, MED vs. IVV, MED vs. VFC, MED vs. VOO, MED vs. LOW, MED vs. GPC

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Medifast, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%NovemberDecember2024FebruaryMarchApril
-57.41%
17.40%
MED (Medifast, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Medifast, Inc. had a return of -52.57% year-to-date (YTD) and -65.78% in the last 12 months. Over the past 10 years, Medifast, Inc. had an annualized return of 2.77%, while the S&P 500 had an annualized return of 10.43%, indicating that Medifast, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-52.57%5.29%
1 month-11.07%-2.47%
6 months-58.30%16.40%
1 year-65.78%20.88%
5 years (annualized)-23.20%11.60%
10 years (annualized)2.77%10.43%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-18.70%-26.64%-4.42%
2023-9.41%-7.60%-4.02%1.27%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MED is 3, indicating that it is in the bottom 3% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.

The Risk-Adjusted Performance Rank of MED is 33
Medifast, Inc.(MED)
The Sharpe Ratio Rank of MED is 11Sharpe Ratio Rank
The Sortino Ratio Rank of MED is 11Sortino Ratio Rank
The Omega Ratio Rank of MED is 22Omega Ratio Rank
The Calmar Ratio Rank of MED is 1010Calmar Ratio Rank
The Martin Ratio Rank of MED is 22Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Medifast, Inc. (MED) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MED
Sharpe ratio
The chart of Sharpe ratio for MED, currently valued at -1.48, compared to the broader market-2.00-1.000.001.002.003.00-1.48
Sortino ratio
The chart of Sortino ratio for MED, currently valued at -2.64, compared to the broader market-4.00-2.000.002.004.00-2.64
Omega ratio
The chart of Omega ratio for MED, currently valued at 0.69, compared to the broader market0.501.001.500.69
Calmar ratio
The chart of Calmar ratio for MED, currently valued at -0.74, compared to the broader market0.001.002.003.004.005.00-0.74
Martin ratio
The chart of Martin ratio for MED, currently valued at -1.79, compared to the broader market0.0010.0020.0030.00-1.79
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.79, compared to the broader market-2.00-1.000.001.002.003.001.79
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.61, compared to the broader market-4.00-2.000.002.004.002.61
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.31, compared to the broader market0.501.001.501.31
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.36, compared to the broader market0.001.002.003.004.005.001.36
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.21, compared to the broader market0.0010.0020.0030.007.21

Sharpe Ratio

The current Medifast, Inc. Sharpe ratio is -1.48. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-2.00-1.000.001.002.003.00NovemberDecember2024FebruaryMarchApril
-1.48
1.79
MED (Medifast, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

Medifast, Inc. granted a 10.35% dividend yield in the last twelve months. The annual payout for that period amounted to $3.30 per share.


PeriodTTM202320222021202020192018201720162015
Dividend$3.30$4.95$6.56$5.68$4.52$3.38$2.19$1.44$1.07$0.25

Dividend yield

10.35%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%

Monthly Dividends

The table displays the monthly dividend distributions for Medifast, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00$0.00
2023$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$1.65$0.00$0.00$0.00
2022$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64$0.00$0.00$1.64
2021$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42$0.00$0.00$1.42
2020$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13$0.00$0.00$1.13
2019$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$1.13
2018$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.75
2017$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.32$0.00$0.00$0.48
2016$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.32
2015$0.25

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%10.4%
Medifast, Inc. has a dividend yield of 10.35%, which means its dividend payment is significantly above the market average.
Payout Ratio
200.0%400.0%600.0%800.0%36.2%
Medifast, Inc. has a payout ratio of 36.22%, which is quite average when compared to the overall market. This suggests that Medifast, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%NovemberDecember2024FebruaryMarchApril
-89.17%
-4.42%
MED (Medifast, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Medifast, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medifast, Inc. was 98.33%, occurring on Dec 23, 1999. Recovery took 534 trading sessions.

The current Medifast, Inc. drawdown is 89.17%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.33%Feb 9, 19941254Dec 23, 1999534Dec 27, 20021788
-89.35%Jun 1, 2021723Apr 15, 2024
-85.56%Nov 7, 2003330Mar 2, 2005316Jun 2, 2006646
-83.16%Jun 22, 2006611Nov 21, 2008204Sep 16, 2009815
-78.91%Sep 13, 2018380Mar 18, 2020215Jan 25, 2021595

Volatility

Volatility Chart

The current Medifast, Inc. volatility is 13.37%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
13.37%
3.35%
MED (Medifast, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medifast, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items